Mark Linch
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cell Biology top 5%
Papers in
- Oncology 36
- Cancer Immunotherapy and Biomarkers 25
- Peptidase Inhibition and Analysis 7
-
- Prostate Cancer Treatment and Research 19
- Co-authors
- Peter J. Parker (12 shared papers)Carine Rossé (7 shared papers)Angus J.M. Cameron (5 shared papers)Katrina Boeckeler (2 shared papers)Stéphanie Kermorgant (1 shared paper)Charlotte Benson (6 shared papers)Aisha Miah (4 shared papers)Thomas Powles (7 shared papers)
- Journals
- Journal of Clinical Oncology (22 papers)Annals of Oncology (8 papers)Biochemical Journal (2 papers)European Urology (2 papers)Biochemical Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark Linch
70 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 115
- Oncology 520
- Cell Biology 233
- Molecular Biology 842
- Pulmonary and Respiratory Medicine 361
- Cancer Research 155
Countries citing papers authored by Mark Linch
This map shows the geographic impact of Mark Linch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Linch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Linch more than expected).
Fields of papers citing papers by Mark Linch
This network shows the impact of papers produced by Mark Linch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Linch. The network helps show where Mark Linch may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Linch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 370 | |
| 2 | 2014 | 171 | |
| 3 | 2019 | 137 | |
| 4 | 2009 | 87 | |
| 5 | 2014 | 78 | |
| 6 | 2013 | 77 | |
| 7 | 2017 | 73 | |
| 8 | 2011 | 68 | |
| 9 | 2018 | 65 | |
| 10 | 2013 | 48 | |
| 11 | 2006 | 46 | |
| 12 | 2016 | 44 | |
| 13 | 2020 | 42 | |
| 14 | 2019 | 42 | |
| 15 | 2011 | 42 | |
| 16 | 2020 | 37 | |
| 17 | 2019 | 31 | |
| 18 | 2021 | 30 | |
| 19 | 2017 | 29 | |
| 20 | 2014 | 27 |
About Mark Linch
Mark Linch is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 71 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (25 papers), Prostate Cancer Treatment and Research (19 papers), Bladder and Urothelial Cancer Treatments (14 papers), Protein Kinase Regulation and GTPase Signaling (9 papers), Peptidase Inhibition and Analysis (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Urinary and Genital Oncology Studies (6 papers). The work is most often cited by research in Oncology (520 citations), Cell Biology (233 citations), Molecular Biology (842 citations), Pulmonary and Respiratory Medicine (361 citations) and Cancer Research (155 citations). Mark Linch has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Peter J. Parker, Carine Rossé, Angus J.M. Cameron, Katrina Boeckeler, Stéphanie Kermorgant, Charlotte Benson, Aisha Miah, Thomas Powles, Ian Judson and Khin Thway. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Biochemical Journal, European Urology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.